Neogen Chemicals has notified the stock exchanges of a forthcoming Board of Directors meeting scheduled for Saturday, May 16, 2026, to consider audited financial results for Q4FY26. Additionally, the company has announced an Earnings Conference Call on Monday, May 18, 2026, at 4:30 p.m. IST for analysts and investors to discuss the results for the quarter and financial year ended March 31, 2026. Both intimations were filed pursuant to Regulation 29, 30, 33, 51, and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting has been convened to consider, approve, and take on record the following key items:

Q4FY26 Earnings Conference Call

Following the board meeting, Neogen Chemicals will host an Earnings Conference Call on May 18, 2026, at 4:30 p.m. IST. The call will commence with a brief management discussion on the Q4FY26 results, followed by an interactive Question & Answer session. Senior members of the management team will represent the company during the call. The company has noted that no Unpublished Price Sensitive Information will be shared during the call.

Participants can join the call using the following dial-in details:

Trading Window Closure

Neogen Chemicals had previously informed exchanges, vide an intimation letter dated March 27, 2026, that the trading window closure period commenced from April 1, 2026. The trading window will remain closed until 48 hours after the declaration of the audited financial results for the quarter and financial year ended March 31, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Regulatory Filing Details

The intimations, dated May 12, 2026, were filed with both BSE Limited and the National Stock Exchange of India Limited. The company has also made this information available on its official website at www.neogenchem.com . The filings were signed by Unnati Kanani, Company Secretary and Compliance Officer (Membership No: A35131).

About Neogen Chemicals Limited

Incorporated in 1989, Neogen Chemicals is one of India's leading manufacturers of Bromine-based and Lithium-based specialty chemicals, with a product portfolio of over 258 products. Its products find application across pharmaceuticals, agrochemicals, engineering fluids, electronic chemicals, polymer additives, water treatment, construction chemicals, aroma chemicals, and lithium-ion battery materials for energy storage and Electric Vehicle (EV) applications. The company operates four manufacturing facilities located in Mahape (Navi Mumbai), Dahej SEZ (Bharuch), Karakhadi (Vadodara), and Patancheru (Hyderabad). Through its wholly owned subsidiary Neogen Ionics Limited, the company has established one of the earliest LIB electrolyte facilities at the Dahej SEZ site.

Dr. Harin Haridas Kanani, promoter of neogen chemicals , has submitted a revised disclosure to BSE Limited and National Stock Exchange of India Limited regarding the creation of a pledge on 20,19,167 equity shares. The pledged shares constitute 7.65% of the company's paid-up capital and were pledged in favor of Axis Trustee Services Limited on April 13, 2026.

Details of the Pledge

The disclosure was made under Regulation 31 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The pledge was created to facilitate the borrowing or raising of funds by Cadamba Solutions Private Limited, a promoter group member of the company, from Avendus Structured Credit Fund III. The revised disclosure was submitted on April 29, 2026, following an email from BSE Limited dated April 27, 2026, regarding discrepancies in the earlier disclosure.

Promoter Holding and Encumbrance Details

The following table provides details of the promoter holdings and encumbrance as per the disclosure:

Specific Encumbrance Event

The specific details of the encumbrance event for Dr. Harin Haridas Kanani are as follows:

The disclosure was digitally signed by Dr. Harin Haridas Kanani on April 29, 2026, and addressed to the corporate services departments of both stock exchanges. A copy was also marked to Unnati Kanani, Company Secretary and Compliance Officer of Neogen Chemicals Limited.